Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV sedatives for severe acute agitation in the emergency department
ACTRN12614000980639Phase 4Completed
- Sponsor
- Austin Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of midazolam, droperidol and olanzapine in agitation (acute) and Aggression (not a disease; see rationale) (3 arms), sponsored by Austin Hospital. Primary endpoint: Time to adequate sedation. Started Oct 2014; status: completed.
02
Drugs
midazolamdroperidololanzapine
03
Conditions
agitation (acute)Aggression (not a disease; see rationale)
Beyond the preview
Go deeper on ACTRN12614000980639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000980639.